Skip to Content

Notice

Advisory Committee on Breast Cancer in Young Women (ACBCYW)

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee:

Time and Date: 9:00 a.m.-11:00 a.m. EDT, April 16, 2013.

Place: The meeting will be held via teleconference.

Teleconference login information is as follows: For Public:

TOLL-FREE PHONE #: 800-857-4875

Participant passcode: 9377

Net Conference URL: https://www.mymeetings.com/​nc/​join/​

Conference number: PW8921926

Audience passcode: 9377 or Public can join the event directly: https://www.mymeetings.com/​nc/​join.php?​i=​PW8921926&​p=​9377&​t=​c

There is also a toll number for anyone outside of the USA:

TOLL #: 1-212-287-1661

Participant passcode: 9377

Please go to the ACBCYW meeting Web page to register for this meeting: http://www.cdc.gov/​cancer/​breast/​what_​cdc_​is_​doing/​conference.htm.

Status: Open to the public, limited only by the number of phone lines available.

Purpose: The committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and dissemination of credible appropriate messages and resource materials.

Matters To Be Discussed: The agenda will include discussions on approaches to increase awareness of clinicians/practitioners regarding topics such as breast health, symptoms, diagnosis, and treatment of breast cancer in young women; and information needs and delivery mechanisms for women at higher risks for developing breast cancer. These discussions will be directed toward the final review and approval of formal recommendations on these topics.

Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Temeika L. Fairley, Ph.D., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway NE., Mailstop K52, Atlanta, Georgia, 30341, Telephone (770) 488-4518, Fax (770) 488-4760, Email: acbcyw@cdc.gov.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and Agency for Toxic Substances and Disease Registry.

Start Signature

Dana Redford,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 2013-06946 Filed 3-26-13; 8:45 am]

BILLING CODE 4163-18-P